Keywords: انسولین glargine; dulaglutide; estimated glomerular filtration rate; glycosylated hemoglobin; insulin glargine;
مقالات ISI انسولین glargine (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: انسولین glargine; Insulin; Insulin glargine; Insulin detemir; Hyperinsulinemia; Cancer progression;
Keywords: انسولین glargine; Colombia; cost-effectiveness analysis; diabetes; dulaglutide; insulin glargine; liraglutide; quality-adjusted life-years;
Keywords: انسولین glargine; Insulin degludec; Insulin glargine; Type 2 diabetes; Blood glucose variability; Quality of life;
Keywords: انسولین glargine; 1,5-AG; 1,5-anhydroglucitol; AUC; area under curve; CGM; Continuous Glucose Monitoring; CI; confidence interval; CONGAn; Continuous Overlapping Net Glycemic Action; CV; Coefficient of Variance; DCCT; Diabetes Control and Complication Trial; FPG; fasting p
Keywords: انسولین glargine; Clinical trial; Continuous glucose monitoring; Basal-bolus insulin therapy; Insulin degludec; Insulin glargine; Type 1 diabetes
Keywords: انسولین glargine; basal insulin; elderly; glycemic control; insulin glargine; type 2 diabetes
Keywords: انسولین glargine; Diabetes mellitus; Insulina basal; Análogo de insulina; Insulina degludec; Insulina glarginaDiabetes mellitus; Basal insulin; Insulin analogue; Insulin degludec; Insulin glargine
Keywords: انسولین glargine; cost comparison; insulin detemir; insulin glargine; type 2 diabetes
Morning administration of 0.4Â U/kg/day insulin glargine 300Â U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100Â U/mL in type 1 diabetes
Keywords: انسولین glargine; Insulin degludec; Insulin glargine; Pharmacodynamic; Pharmacokinetic; Type 1 diabetes; GIR-AUC0-24; area under the GIR over time curve; GIR-smFL0-24; fluctuation of the smoothed glucose infusion rate; LOESS; locally weighted regression in smoothing sc
Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control
Keywords: انسولین glargine; Dapagliflozin; Type 2 diabetes; Insulin glargine;
Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?
Keywords: انسولین glargine; Basal insulin; Duration of insulin therapy; Insulin glargine; Type 2 diabetes mellitus;
Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100â¯units/mL: A patient-level pooled analysis of 16 randomised controlled trials
Keywords: انسولین glargine; Type 2 diabetes; Asian; Insulin glargine; Meta-analysis;
Baseline factors associated with better response to insulin lispro low mixture or insulin glargine: A post hoc analysis of the DURABLE study
Keywords: انسولین glargine; Type 2 diabetes mellitus; Insulin lispro mix 75/25; Insulin glargine; Baseline characteristics; Gradient-boosting method; Treatment response;
Contrôle glycémique avec insuline glargine : étude observationnelle menée au Maroc auprès de patients diabétiques de type 2 insuffisamment contrôlés par metformine, seule ou en association avec un sulfamide hypoglycémiant et/ou une insuline basale
Keywords: انسولین glargine; Diabète de type 2; contrôle glycémique; insuline glargine; Maroc; Type 2 diabetes; glycemic control; insulin glargine; Morocco;
Expanded Basal Insulin Options for Type 2 Diabetes Mellitus
Keywords: انسولین glargine; basal insulin; concentrated insulin; insulin degludec; insulin glargine; U-500 insulin;
TITRATION: A Randomized Study to Assess 2 Treatment Algorithms with New Insulin Glargine 300 units/mL
Keywords: انسولین glargine; A1C; glycemic control; hypoglycemia; insulin glargine; patient satisfaction; titration algorithm; A1c; régulation de la glycémie; hypoglycémie; insuline glargine; satisfaction des patients; algorithme de titration;
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month ex
Keywords: انسولین glargine; Glycaemic control; Hypoglycaemia; Insulin glargine; Type 2 diabetes; AE; adverse event; ANCOVA; analysis of covariance; BL; baseline; BMI; body mass index; CI; confidence interval; FPG; fasting plasma glucose; Gla-100; glargine 100; Gla-300; glargine 300;
The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study
Keywords: انسولین glargine; choice; decomposition analysis; insulin glargine; liraglutide; personalized medicine; real-world; type 2 diabetes;
Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes
Keywords: انسولین glargine; FGF21; Liraglutide; Insulin glargine; Hypoglycemic effect; Type 2 diabetes;
Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR®/ABASAGLAR®) approved in the European Union
Keywords: انسولین glargine; Biosimilar insulin; Glucodynamics; Insulin glargine; Nonclinical; Pharmacokinetics; Pharmacology; Preclinical; Rats; Toxicology; ANOVA; analysis of variance; AUC0-24hr; exposure over 24-hour period; BHI; biosynthetic human insulin; CHMP; Committee on Me
Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100Â U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy
Keywords: انسولین glargine; Sulfonylurea; Metformin; Insulin glargine; Neutral protamine Hagedorn insulin; Glycaemic control; Hypoglycaemia;
Instauration d'une insulinothérapie chez le patient diabétique de type 2 en médecine générale : Comparaison de l'étude belge InsuStar avec quelques études françaises et internationales
Keywords: انسولین glargine; Diabète de type 2; inertie clinique; insuline glargine; insulinothérapie; médecine générale; Type 2 diabetes; clinical inertia; insulin glargine; insulin therapy; general practitioner;
Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals
Keywords: انسولین glargine; Insulin glargine; Insulin glulisine; Neutral protamine lispro; Insulin lispro; Standardized meals; Type 1 diabetes
Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300Â U/mL compared with glargine 100Â U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension)
Keywords: انسولین glargine; Insulin glargine; Type 1 diabetes; Glycaemic control; Hypoglycaemia;
Effect of insulin glargine on glycemic control in adolescents with type 1-diabetes
Keywords: انسولین glargine; Type 1 diabetes; Insulin; NPH; Insulin glargine; Hypoglycemia; HbA1c
Ãquilibre glycémique et satisfaction de patients diabétiques de type 2 insuffisamment contrôlés au Maroc : résultats après 6 mois de traitement par insuline glargine
Keywords: انسولین glargine; Diabète de type 2; contrôle glycémique; Maroc; insuline glargine; satisfaction du patient; Type 2 diabetes; glycemic control; Morocco; insulin glargine; patient's satisfaction;
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Keywords: انسولین glargine; Type 2 diabetes mellitus; Insulin glargine; Oral antidiabetes drug; Glycemic control; Hypoglycemia;
Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-o
Keywords: انسولین glargine; Hypoglycemia; Insulin glargine; Type 2 diabetes; Microvascular complications; Multivariate analysis;
Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respi
Keywords: انسولین glargine; Type 2 diabetes; Corticosteroids; Insulin glargine; Basal–bolus insulin regimen; Continuous glucose monitoring; Respiratory disease
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
Keywords: انسولین glargine; Meta-analysis; Diabetes; Hypoglycaemia; Insulin therapy; Fasting plasma glucose; ANCOVA; analysis of covariance; CI; confidence interval; FPG; fasting plasma glucose; IDeg; insulin degludec; IDet; insulin detemir; IGlar; insulin glargine; LOCF; last obser
Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial
Keywords: انسولین glargine; EASIE; A1c; Insulin glargine; Metformin; Sitagliptin; Type 2 diabetes;
Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes
Keywords: انسولین glargine; Long-acting hypoglycemic effects; Type 1 diabetic mice; PEGylated FGF21; Insulin glargine; Glycolysis; Gluconeogenesis;
Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
Keywords: انسولین glargine; GALAPAGOS; Hypoglycemia; Insulin glargine; Premixed insulin; Type 2 diabetes;
Eficacia y seguridad de una estrategia basal plus en pacientes con diabetes mellitus tipo 2 en la práctica clínica especializada. El estudio Basal Plus en España
Keywords: انسولین glargine; Diabetes mellitus tipo 2; Atención especializada; Insulina glargina; Insulina glulisina; Hipoglucemias; Control glucémico; Insulina basal; Insulina prandialType 2 diabetes mellitus; Specialized care; Insulin glargine; Insulin glulisine; Hypoglycemias; Gly
Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice
Keywords: انسولین glargine; FGF-21; Insulin glargine; PEGylation; Diabetes; Hypoglycaemic effect
Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial
Keywords: انسولین glargine; Insulin glargine; Costs
Efficacy and Safety of Weight-based Insulin Glargine Dose Titration Regimen Compared With Glucose Level- and Current Dose-based Regimens in Hospitalized Patients With Type 2 Diabetes: A Randomized, Controlled Study
Keywords: انسولین glargine; Hyperglycemia; Insulin glargine; Dose titration;
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy
Keywords: انسولین glargine; Insulin glargine; Basal human insulins; Propensity-score matching; Administrative data; Macrovascular complications
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials
Keywords: انسولین glargine; Type 2 diabetes; Basal insulin initiation and maintenance; Glycaemic efficacy; Hypoglycaemia; Insulin glargine;
Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Mellitus
Keywords: انسولین glargine; cost-effectiveness; insulin glargine; sitagliptin; type 2 diabetes;
Octreotide for the Treatment of Hypoglycemia After Insulin Glargine Overdose
Keywords: انسولین glargine; insulin glargine; octreotide; overdose; hypoglycemia; intensive care
Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy
Keywords: انسولین glargine; Diabetes mellitus type 2; exenatide; glucagon-like peptide-1; hemoglobin A glycosylated; insulin glargine
Initiating Basal Insulin Therapy in Type 2 Diabetes: Practical Steps to Optimize Glycemic Control
Keywords: انسولین glargine; Basal insulin; Insulin detemir; Insulin glargine
Estudio observacional de eficacia y seguridad del cambio de insulina NPH a glargina en atención primaria. Estudio LAURA
Keywords: انسولین glargine; Diabetes mellitus tipo 2; Atención primaria; Insulina glargina; Insulina NPH; Hipoglucemias; Control glucémicoType 2 diabetes mellitus; Primary care; Insulin glargine; NPH insulin; Hypoglycaemias; Blood glucose control
Effect of gender on treatment outcomes in type 2 diabetes mellitus
Keywords: انسولین glargine; Gender; Glycemic control; Hypoglycemia; Insulin glargine; Type 2 diabetes mellitus
Depressive phenotypes evoked by experimental diabetes are reversed by insulin
Keywords: انسولین glargine; Diabetes; Streptozotocin; Insulin; Insulin glargine; Depression; BDNF; Corticosterone; Tail suspension; ICSS; Neurogenesis; Behavior;
Peak-less hypoglycemic effect of insulin glargine by complexation with maltosyl-β-cyclodextrin
Keywords: انسولین glargine; Insulin glargine; Maltosyl-β-cyclodextrin; Diabetes; Subcutaneous injection; Peak-less hypoglycemic effect
Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study
Keywords: انسولین glargine; Type 2 diabetes; Basal-bolus; Prandial insulin; Insulin glargine; Insulin glulisine; Randomised trialDiabète de type 2; Schéma basal-bolus; Insuline prandiale; Insuline glargine; Insuline glulisine; Essai randomisé
Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferio
Keywords: انسولین glargine; diabetes mellitus; type 2; exenatide; GLP-1 receptor agonist; insulin glargine; Japanese; once weekly;